Metastatic Lung Adenocarcinoma Received Combined 177 Lu-FAP-2286 Radiation Therapy and Targeted Therapy. Yang H, Liu H, Zhang Y, Zhang Y, et al. Clin Nucl Med 2024;49:569-571.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang H, Liu H, Zhang Y, Zhang Y, et al. Metastatic Lung Adenocarcinoma Received Combined 177 Lu-FAP-2286 Radiation Therapy and Targeted Therapy. Clin Nucl Med 2024;49:569-571.
PMID: 38598734